Log in to save to my catalogue

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radio...

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d311f429df8245cd9ffa0794a6620b13

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma

About this item

Full title

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Case reports in endocrinology, 2017-01, Vol.2017 (2017), p.1-5

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Background and Importance. In the last eight years temozolomide (TMZ) has been used as the last-line treatment modality for aggressive pituitary tumors to be applied after the failure of surgery, medical therapy, and radiotherapy. The objective was to achieve a rapid control of tumor growth and hormone normalization with concurrent chemoradiotherap...

Alternative Titles

Full title

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d311f429df8245cd9ffa0794a6620b13

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d311f429df8245cd9ffa0794a6620b13

Other Identifiers

ISSN

2090-6501

E-ISSN

2090-651X

DOI

10.1155/2017/2419590

How to access this item